Liver Cancer
Caboxen Cabozantinib 80 mg Capsules
Caboxen (Cabozantinib 80 mg Capsules) is a highly effective treatment for advanced renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC). As a tyrosine kinase inhibitor, Cabozantinib targets multiple pathways involved in tumor growth and angiogenesis, helping to slow the progression of cancer and shrink tumors. Our super specialty pharmacy provides Caboxen with personalized treatment plans and expert support to ensure the best possible outcomes for patients. Trust us for high-quality cancer care and comprehensive support throughout your treatment journey.
₱0
Tucaxen Tucatinib 150 mg Tablet
TABLE OF CONTENT
Mode of Action
Indications
Dosage and Administration
Precautions
Side Effects
Tucaxen Tucatinib 150 mg Tablet is a cutting-edge medication meticulously engineered to target specific proteins involved in the growth and spread of cancer cells. Each tablet contains 150 mg of tucatinib, a potent tyrosine kinase inhibitor renowned for its efficacy in treating certain types of advanced or metastatic cancers.
Mode of Action: Tucatinib, the active ingredient in Tucaxen Tucatinib 150 mg Tablet, selectively inhibits the activity of human epidermal growth factor receptor 2 (HER2) and tyrosine kinase, key drivers of cancer cell proliferation and survival. By disrupting these signaling pathways, tucatinib helps suppress tumor growth and metastasis.
Indications: Tucaxen Tucatinib 150 mg Tablet is indicated for the treatment of:
- HER2-Positive Metastatic Breast Cancer
- HER2-Positive Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
Dosage and Administration: The recommended dosage of Tucaxen Tucatinib 150 mg Tablet is one tablet (150 mg) to be taken orally twice daily with or without food. The dosage may vary based on individual patient factors and concurrent treatments. Patients should adhere strictly to the prescribed regimen provided by a healthcare professional.
Precautions:
- Prior to initiating treatment with Tucaxen Tucatinib 150 mg Tablet, patients should undergo thorough medical evaluation, including assessment of cardiac function and liver enzymes.
- Close monitoring of cardiac function, liver function, and gastrointestinal symptoms is essential during therapy.
- Tucatinib may interact with certain medications, so patients should inform their healthcare provider about all concurrent medications, including over-the-counter drugs and herbal supplements.
Side Effects: Common side effects associated with Tucaxen Tucatinib 150 mg Tablet may include:
- Diarrhea
- Nausea
- Fatigue
- Vomiting
- Elevated liver enzymes
- Decreased appetite
- Hand-foot syndrome (palmar-plantar erythrodysesthesia)
₱120,000 ₱108,000
MabAll Rituximab 500mg Vail
MabAll Rituximab 500mg Vial is a powerful medication designed to target specific cells in the body involved in the immune response. Each vial contains 500mg of rituximab, a monoclonal antibody that selectively targets CD20-positive B-cells, which are often implicated in certain types of cancers and autoimmune diseases.
Mode of Action: Rituximab, the active ingredient in MabAll Rituximab 500mg Vial, works by binding to CD20 antigen present on the surface of B-cells. This binding triggers various immune mechanisms, including antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity, leading to the destruction of targeted B-cells. By depleting these abnormal B-cells, rituximab helps modulate the immune response and combat diseases.
Indications: MabAll Rituximab 500mg Vial is indicated for the treatment of:
- Non-Hodgkin's Lymphoma
- Chronic Lymphocytic Leukemia
- Rheumatoid Arthritis
- Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
- Microscopic Polyangiitis
Dosage and Administration: The recommended dosage of MabAll Rituximab 500mg Vial varies depending on the specific condition being treated, the patient's weight, and other factors. It is typically administered intravenously by a healthcare professional over a specified period. Dosage and administration should be tailored to the individual patient's needs and medical history.
Precautions:
- Prior to initiating treatment with MabAll Rituximab 500mg Vial, patients should undergo thorough medical evaluation, including screening for hepatitis B virus (HBV) infection.
- Close monitoring for signs of infusion reactions, infections, and other adverse effects is essential during and after rituximab therapy.
- Patients should receive appropriate premedication to reduce the risk of infusion-related reactions.
- Rituximab should be used with caution in patients with a history of cardiac or pulmonary conditions.
Side Effects: Common side effects associated with MabAll Rituximab 500mg Vial may include:
- Infusion reactions (fever, chills, nausea, headache, rash)
- Fatigue
- Infections (upper respiratory tract infections, urinary tract infections)
- Low white blood cell count (neutropenia)
- Low platelet count (thrombocytopenia)
- Hypertension (high blood pressure)
₱18,000 ₱15,000
Cazanat Cabozantinib 60mg Tablet
Cazanat Cabozantinib 60mg Tablet is a potent medication specifically formulated to combat certain types of advanced cancer. Each tablet contains 60mg of cabozantinib, a targeted therapy known for its efficacy in treating renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer.
₱40,000 ₱37,000